How big is the implantable cardiac devices market today, and what are its future growth expectations?
The implantable cardiac devices market size has grown strongly in recent years. It will grow from $12.34 billion in 2024 to $13.46 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to advances in medical technology, increasing prevalence of cardiovascular diseases, growing aging population, improvements in device reliability and longevity, rising awareness, and early diagnosis of heart conditions.
The implantable cardiac devices market size is expected to see strong growth in the next few years. It will grow to $18.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to technological advancements in device functionality, increasing demand for minimally invasive procedures, growing geriatric population, rising healthcare expenditures, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of digital health and remote monitoring, development of next-generation devices with enhanced features, growth in personalized and patient-specific cardiac solutions, emphasis on cost-effectiveness and value-based healthcare, increasing focus on preventive cardiology, and early intervention.
Get Your Free Sample of The Global Implantable Cardiac Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19097&type=smp
What have been the primary factors driving the implantable cardiac devices market’s growth?
The rising incidence of heart diseases is expected to propel the growth of the implantable cardiac devices market. The rise in heart diseases can be attributed to the increasing prevalence of risk factors such as poor diet, sedentary lifestyle, obesity, and chronic conditions like diabetes and hypertension. Additionally, aging populations and rising stress levels further contribute to the higher incidence of cardiovascular conditions. Implantable cardiac devices are used to manage and treat conditions such as heart failure, arrhythmias, and coronary artery disease. This increased need accelerates innovation and investment in developing new and improved cardiac devices to address the growing patient population and enhance treatment outcomes. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart disease resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the rising incidence of heart disease drives the growth of the implantable cardiac devices market.
What are the key segments within the implantable cardiac devices market?
The implantable cardiac devicesmarket covered in this report is segmented –
1) By Type: Pacemaker, Implantable Cardioverter Defibrillator (ICD), Biventricular Implantable Cardioverter Defibrillator (BI-V ICD)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Pacemaker: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Rate-Responsive Pacemakers
2) By Implantable Cardioverter Defibrillator (ICD): Transvenous ICDs, Subcutaneous ICDs, Wearable Cardioverter Defibrillators
3) By Biventricular Implantable Cardioverter Defibrillator (BI-V ICD): Standard BI-V ICDs, Advanced BI-V ICDs with Cardiac Resynchronization Therapy (CRT)
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/implantable-cardiac-devices-global-market-report
Which key players are shaping the implantable cardiac devices market?
Major companies operating in the implantable cardiac devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, Lepu Medical Technology, MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Berlin Heart GmbH, EBR Systems Inc., Defibtech LLC, CVRx Inc., Progetti Srl, Endotronix Inc., Jarvik Heart Inc., Xeltis AG, Carmat SA, Windmill Cardiovascular Systems Inc
How will emerging trends drive the implantable cardiac devices market throughout the forecast period?
Major companies operating in the implantable cardiac devices market focus on enhancing compatibility with diagnostic tools such as AutoMRI to extend device lifespan and improve patient safety. The AutoMRI function in implantable cardiac defibrillators automatically adjusts the device settings to ensure safe operation during MRI scans, enhancing patient care while allowing access to advanced imaging technology. For instance, in October 2023, MicroPort CRM, a France-based medical device company, launched the ULYS implantable cardioverter defibrillator (ICD) and INVICTA defibrillation leads in Japan, featuring advanced technology with low current consumption for extended device lifespan and MRI compatibility. The ULYS ICD incorporates the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, while the INVICTA lead delivers precise pacing and defibrillation therapy, demonstrating a 100% implantation success rate and 97.4% complication-free rate in clinical trials.
How do regional factors impact the implantable cardiac devices market, and which region is the largest contributor?
North America was the largest region in the implantable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardiac devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Implantable Cardiac Devices Market Report 2025 Offer?
The implantable cardiac devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Implantable cardiac devices are medical devices surgically placed inside the body to help manage heart conditions, particularly those related to abnormal heart rhythms (arrhythmias) or heart failure. These devices monitor the heart’s activity and, in many cases, deliver electrical impulses to regulate or correct abnormal heartbeats.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19097
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
